Thymus repopulation after allogeneic reconstitution in hematological malignancies.

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Allogeneic transplantation in tumor-bearing hosts requires donor T-cell tolerance for effective vaccination.
• Hematological malignancies can impair thymus repopulation and central tolerance induction post-transplant.

Purpose of the Study:

• To develop a reconstitution protocol supporting thymus repopulation and tolerance induction in allogeneically reconstituted, lymphoma-bearing hosts.
• To establish a basis for active vaccination strategies in this patient population.

Main Methods:

• Lymphoma-bearing mice underwent myeloreductive conditioning and hematopoietic progenitor cell reconstitution.
• Key readouts included T-cell recovery, graft-versus-host disease (GVHD), anti-tumor cytotoxicity, and tumor rejection.
• Protocol modifications involved NK cell depletion, T cell-depleted bone marrow transfer, IL-7 support, and administration of donor CD4(+)CD8(+) thymocytes.

Main Results:

• Initial protocols in tumor-free mice achieved reconstitution without severe GVHD.
• In lymphoma models, poor thymus repopulation led to increased GVHD, hindering vaccination.
• Enhanced conditioning, IL-7, and particularly donor thymocytes improved thymus repopulation and enabled vaccination.
• The optimized protocol improved survival rates and survival time in lymphoma-bearing mice without increasing GVHD.

Conclusions:

• A modified reconstitution protocol can overcome the negative impact of hematological malignancies on thymus repopulation and central tolerance.
• The addition of donor T-progenitor cells is key to correcting these deficits.
• This approach facilitates active vaccination and improves outcomes in allogeneically transplanted, lymphoma-bearing hosts.